- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
"Surprise" corporate earnings can fool investors
The Dow is up; more public corporations have been reporting positive quarterly earnings-but which companies are really performing well?
The Dow is up; more public corporations have been reporting positive quarterly earnings-but which companies are really performing well?
"Earnings are surprisingly on the upside, not due to a great increase in top-line revenue growth, but because of cost-cutting measures," says investment adviser Patrick W. Fisher, CFA, with Schneider Downs Wealth Management Advisors LP in Pittsburgh. "That's not the best reason you want to see for improved earnings."
Other than revenue growth, a better sign of a company's health is news about it opening a new facility, launching a new product line, or adding personnel, according to Fisher. Regardless, Fisher doesn't advise trying to pick stocks on a one-by-one basis.
